<DOC>
	<DOCNO>NCT00823875</DOCNO>
	<brief_summary>Randomized , control , open label , multicentre clinical study . The patient accordance subject inclusion exclusion criterion randomize A group : Routine treatment B group : Routine treatment+ Cilostazol ; C group : Routine treatment + Probucol ; D group : Routine treatment+ Cilostazol+ Probucol .</brief_summary>
	<brief_title>Study Cilostazol Probucol Alone Combination Atherosclerosis Related Biomarker -- -atherosclerosis Cerebral Infarction Patient Study Subject</brief_title>
	<detailed_description>Efficacy index : After 12 week treatment , change difference arteriosclerosis relate biomarker 4 modality group . Pharmacokinetics : After 12 week treatment , study medication plasma concentration include Probucol , Cilostazol , Cilostazol metabolism OPC-13015 OPC-13213 measure . Safety evaluation : Analysis abnormality Adverse Event , Vital Sign , Physical Examination , 12-lead ECG , Laboratory Tests ( include blood routine examination , routine urine analysis , blood biochemistry examination , glycosylated hemoglobin ) 4 modality group .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Intracranial Arteriosclerosis</mesh_term>
	<mesh_term>Cilostazol</mesh_term>
	<mesh_term>Probucol</mesh_term>
	<criteria>1 . 40～80yearold male female 2 . By brain CT MRI result , cerebral infarction clarify diagnosis within 1 year 3 . With atherosclerosis , atherosclerosis meet least one condition : Clarified diagnosis type 2 diabetes Clarified diagnosis primary hypertension Clarified diagnosis Atherosclerotic stenosis 2 2 region cerebral artery , carotid , extremity artery coronary conformation ultrasonic angiography result 4 . Has Aspirin regularly 1 month registration 5 . Informed Consent Form signature Exclusion criteria： 1 . Has allergic history study drug ( include Probucol Cilostazol ) Aspirin 2 . Had lipidlowing agent within last 3 month ( except Statins ) 3 . Had antiplatelet anticoagulation agent within last 3 month ( except Aspirin ) 4 . Had acute cerebral infarction within last 1 month 5 . Has cardiogenic cerebral embolism 6 . At registration , Modified Rankin Scale ≥ 4 7 . Hemorrhagic tendency hemorrhagic disease ( cerebral hemorrhage , gastrointestinal tract hemorrhage , etc . ) 8 . Had myocardial infarction , angina pectoris within last 3 month 9 . Congestive heart failure 10 . Is pregnant , potentially pregnant , breastfeed 11 . Severe hepatic inadequacy severe renal inadequacy ( AST ALT 2.5 time high upper limit normal value range , serum creatinine 1.2 time high upper limit normal value range ) 12 . Persistent hardly control hypertension ( malignant hypertension , BP &gt; 160/100 mmHg ) 13 . Severe ventricular arrhythmia ( multiple multifocal premature ventricular contraction ) 14 . Has medical history include cardiac syncope primary syncope 15 . Has condition may prolong QT interval ( congenital long QT syndrome , take drug prolong QT interval , hypokalemia hypomagnesemia , etc . ) 16 . Has severe disease ( , malignant tumor , severe anaemia , severe hematologic diabetes mellitus ketoacidosis , nonketotic hyperosmolar diabetic coma , etc . ) 17 . Registered clinical trail within last 3 month 18 . Has vasculitis , moyamoya disease nonatherosclerosis vascular diseases 19 . Other condition could exclude subject study doctor 's judgment</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2010</verification_date>
</DOC>